Axxcess Wealth Management LLC Sells 442 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Axxcess Wealth Management LLC trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.4% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 30,449 shares of the healthcare conglomerate’s stock after selling 442 shares during the quarter. Axxcess Wealth Management LLC’s holdings in UnitedHealth Group were worth $15,948,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Marshall & Sterling Wealth Advisors Inc. bought a new stake in UnitedHealth Group during the 4th quarter worth approximately $26,000. Hurley Capital LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $28,000. Aster Capital Management DIFC Ltd acquired a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $30,000. Kapitalo Investimentos Ltda acquired a new position in shares of UnitedHealth Group during the 4th quarter valued at $41,000. Finally, Copia Wealth Management acquired a new position in shares of UnitedHealth Group during the 4th quarter valued at $42,000. 87.86% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

UNH has been the topic of a number of research reports. Barclays dropped their target price on shares of UnitedHealth Group to $350.00 and set an “overweight” rating on the stock in a research report on Monday, June 2nd. HSBC reiterated a “reduce” rating and set a $270.00 target price (down previously from $490.00) on shares of UnitedHealth Group in a research report on Wednesday, May 21st. Robert W. Baird downgraded shares of UnitedHealth Group from an “outperform” rating to a “neutral” rating and set a $312.00 target price on the stock. in a research report on Wednesday, June 11th. Wolfe Research decreased their price target on shares of UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating for the company in a research note on Tuesday, May 20th. Finally, Mizuho decreased their price target on shares of UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating for the company in a research note on Friday, May 16th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $415.57.

UnitedHealth Group Price Performance

UNH opened at $307.50 on Wednesday. The firm has a market cap of $278.95 billion, a P/E ratio of 12.88, a PEG ratio of 1.45 and a beta of 0.45. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85. The firm has a 50-day moving average of $320.63 and a 200 day moving average of $444.69.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The business had revenue of $109.58 billion for the quarter, compared to analysts’ expectations of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same period last year, the company earned $6.91 earnings per share. On average, research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were issued a dividend of $2.21 per share. The ex-dividend date was Monday, June 16th. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a yield of 2.87%. UnitedHealth Group’s dividend payout ratio is 37.02%.

Insider Transactions at UnitedHealth Group

In other news, Director Kristen Gil purchased 3,700 shares of the stock in a transaction dated Thursday, May 15th. The shares were purchased at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the acquisition, the director owned 3,818 shares in the company, valued at $1,035,327.06. This represents a 3,135.59% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Patrick Hugh Conway sold 589 shares of the firm’s stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the sale, the chief executive officer directly owned 10,398 shares in the company, valued at $3,171,390. This represents a 5.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders bought 109,408 shares of company stock valued at $31,607,768. Company insiders own 0.28% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.